Weight and metabolic changes among virally suppressed people with HIV who switched to co-formulated bictegravir/emtricitabine/tenofovir alafenamideJen‐Yu Hsu, Chien‐Ching Hung, Yu‐Chung Chuang et al.|Journal of Global Antimicrobial Resistance|2023Cited by 10
Incidence of low-level viremia and its impact on virologic failure among people living with HIV-1 who switched to elvitegravir-based antiretroviral therapyJen‐Yu Hsu, Chien‐Ching Hung, Hsin‐Yun Sun et al.|Journal of Global Antimicrobial Resistance|2022Cited by 9